amputation alone: 162 cases (1978–1988). J Am Vet Med Assoc 200:995–999.643 Spugnini, E.P. 2002. Use of hyaluronidase for the treatment of extravasation of chemotherapeutic agents in six dogs. J Am Vet Med Assoc 221:1437–1440, 1419–1420.
644 Spugnini, E.P., T. Azzarito, and S. Fais. 2016. Electrochemotherapy as first line cancer treatment: Experiences from veterinary medicine in developing novel protocols. Curr Drug Targets 16:43–52.
645 Spugnini, E.P. and A. Baldi. 2019. Electrochemotherapy in veterinary oncology: State if the art and perspectives. Vet Clin North Am 49:967–979.
646 Spugnini, E.P., A. Baldi, and B. Vincenzi. 2007. Intraoperative versus postoperative electrochemotherapy in high‐grade soft tissue sarcomas: A preliminary study in a spontaneous feline model. Cancer Chemother Pharmacol 59:375–381.
647 Spugnini, E.P., S. Crispi, A. Scarabello, et al. 2008. Piroxicam and intracavitary platinum‐based chemotherapy for the treatment of advanced mesothelioma in pets: Preliminary observations. J Exp Clin Cancer Res 27:6.
648 Spugnini, E.P., E. Dragonetti, B. Vincenzi, et al. 2006a. Pulse‐mediated chemotherapy enhances local control and survival in a spontaneous canine model of primary mucosal melanoma. Melanoma Res 16:23–27.
649 Spugnini, E.P., S. Fais, T. Azzarito, et al. 2017. Novel instruments for the implementation of electrochemotherapy protocols: From bench side to veterinary clinic. J Cell Physiol 232:490–495.
650 Spugnini, E.P., B. Vincenzi, B. Amadio, et al. 2019. Adjuvant electrochemotherapy with bleomycin and cisplatin combination for canine soft tissue sarcomas: A study of 30 cases. Open Vet J 9:88–93.
651 Spugnini, E.P., B. Vincenzi, F. Baldi, et al. 2006b. Adjuvant electrochemotherapy for the treatment of incompletely resected canine mast cell tumors. Anticancer Res 26:4585–4590.
652 Spugnini, E.P., B. Vincenzi, G. Caruso, et al. 2009. Zoledronic acid for the treatment of appendicular osteosarcoma in a dog. J Small Anim Pract 50:44–46.
653 Stanclift, R.M. and S.D. Gilson. 2004. Use of cisplatin, 5‐fluorouracil, and second‐look laparotomy for the management of gastrointestinal adenocarcinoma in three dogs. J Am Vet Med Assoc 225:1412–1417, 1393.
654 Stanclift, R.M. and S.D. Gilson. 2008. Evaluation of neoadjuvant prednisone administration and surgical excision in treatment of cutaneous mast cell tumors in dogs. J Am Vet Med Assoc 232:53–62.
655 Stefanello, D., G. Avallone, R. Ferrari, et al. 2011. Canine cutaneous perivascular wall tumors at first presentation: Clinical behavior and prognostic factors in 55 cases. J Vet Intern Med 25:1398–1405.
656 Stefanello, D., P. Buracco, S. Sabattini, et al. 2015. Comparison of 2‐ and 3‐category histologic grading systems for predicting the presence of metastasis at the time of initial evaluation in dogs with cutaneous mast cell tumors: 386 cases (2009–2014). J Am Vet Med Assoc 246:765–769.
657 Stepien, R.L., N.T. Whitley, and R.R. Dubielzig. 2000. Idiopathic or mesothelioma‐related pericardial effusion: Clinical findings and survival in 17 dogs studied retrospectively. J Small Anim Pract 41:342–347.
658 Steplewski, Z., C. Rosales, K.A. Jeglum, et al. 1990. in vivo destruction of canine lymphoma mediated by murine monoclonal antibodies. in vivo 4:231–234.
659 Stone, E.A., T.F. George, S.D. Gilson, et al. 1996. Partial cystectomy for urinary bladder neoplasia: Surgical technique and outcome in 11 dogs. J Small Anim Pract 37:480–485.
660 Stone, M.S., M.A. Goldstein, and S.M. Cotter. 1991. Comparison of two protocols for induction of remission in dogs with lymphoma. J Am Anim Hosp Assoc 27:315–321.
661 Stone, E.A., S.J. Withrow, R.L. Page, et al. 1988. Ureterocolonic anastomosis in ten dogs with transitional cell carcinoma. Vet Surg 17:147–153.
662 Straw, R.C., R.A. Lecouteur, B.E. Powers, et al. 1989. Multilobular osteochondrosarcoma of the canine skull: 16 cases (1978–1988). J Am Vet Med Assoc 195:1764–1769.
663 Straw, R.C., S.J. Withrow, E.B. Douple, et al. 1994. The effects of cisdiamminedichloroplatinum II released from D,L,‐polylactic acid implanted adjacent to cortical allografts in dogs. J Orthop Res 12:871–877.
664 Straw, R.C., S.J. Withrow, and B.E. Powers. 1991a. Primary Osteosarcoma of the ulna in 12 dogs. J Am Anim Hosp Assoc 27:323–326.
665 Straw, R.C., S.J. Withrow, and B.E. Powers. 1992. Partial or total hemipelvectomy in the management of sarcomas in nine dogs and two cats. Vet Surg 21:183–188.
666 Straw, R.C., S.J. Withrow, S.L. Richter, et al. 1991b. Amputation and cisplatin for treatment of canine osteosarcoma. J Vet Intern Med 5:205–210.
667 Sun, F., J. Hernandez, J. Ezquerra, et al. 2002. Angiographic study and therapeutic embolization of soft‐tissue fibrosarcoma in a dog: Case report and literature. J Am Anim Hosp Assoc 38:452–457.
668 Swann, H.M. and D.E. Holt. 2002. Canine gastric adenocarcinoma and leiomyosarcoma: A retrospective study of 21 cases (1986–1999) and literature review. J Am Anim Hosp Assoc 38:157–164.
669 Swiderski, J. and S. Withrow. 2009. A novel surgical stapling technique for rectal mass removal: A retrospective analysis. J Am Anim Hosp Assoc 45:67–71.
670 Szivek, A., R.E. Burns, B. Gericota, et al. 2012. Clinical outcome in 94 cases of dermal haemangiosarcoma in dogs treated with surgical excision: 1993–2007. Vet Comp Oncol 10:65–73.
671 Taeymans, O., D.G. Penninck, and R.M. Peters. 2013. Comparison between clinical, ultrasound, CT, MRI, and pathology findings in dogs presented for suspected thyroid carcinoma. Vet Radiol Ultrasound 54:61–70.
672 Takahashi, M., H. Tomiyasu, E. Hotta, et al. 2014. Clinical characteristics and prognostic factors in dogs with histiocytic sarcomas in Japan. J Vet Med Sci 76:661–666.
673 Tan‐Coleman, B., J. Lyons, C. Lewis, et al. 2013. Prospective evaluation of a 5 x 4 Gy prescription for palliation of canine nasal tumors. Vet Radiol Ultrasound 54:89–92.
674 Tater, G., N. Eberle, S. Hungerbuehler, et al. 2012. Ventricular fractional shortening in 108 dogs with malignant lymphoma undergoing chemotherapy with a cyclic combination protocol including doxorubicin. Tierarztl Prax Ausg K Kleintiere Heimtiere 40:261–266.
675 Taylor, F., R. Gear, T. Hoather, et al. 2009. Chlorambucil and prednisolone chemotherapy for dogs with inoperable mast cell tumours: 21 cases. J Small Anim Pract 50:284–289.
676 Taylor, C.W. and S. Kumar. 2005. The effect of immediate breast reconstruction on adjuvant chemotherapy. Breast 14:18–21.
677 Tellado, M.N., F.H. Maglietti, S.D. Michinski, et al. 2020. Electrochemotherapy in treatment of canine oral malignant melanoma and factors influencing treatment outcome. Radiol Oncol 54:68–78.
678 Tepper, L.C., I.B. Spiegel, and G.J. Davis. 2011. Diagnosis of erythema multiforme associated with thymoma in a dog and treated with thymectomy. J Am Anim Hosp Assoc 47:e19–e25.
679 Thamm, D.H., E.A. Mauldin, and D.M. Vail. 1999. Prednisone and vinblastine chemotherapy for canine mast cell tumor‐‐41 cases (1992–1997). J Vet Intern Med 13:491–497.
680 Thamm, D.H., M.M. Turek, and D.M. Vail. 2006. Outcome and prognostic factors following adjuvant prednisone/vinblastine chemotherapy for high‐risk canine mast cell tumour:
